SUMMER RICHARDS: Open Payments
NPI 1326385840 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,145 in 33 payments from 7 companies in 2025. Trend: 2023 $579 · 2024 $180 · 2025 $2,145
Travel & lodging: $1,342Food & beverage: $713Education: $90
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 7 | $1,641 |
| MAYNE PHARMA COMMERCIAL LLC | 19 | $234 |
| Astellas Pharma US Inc | 1 | $90 |
| Sumitomo Pharma America, Inc. | 3 | $72 |
| Medtronic, Inc. | 1 | $70 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $17 |
Products named: Axonics, BIJUVA, INTERSTIM, MYFEMBREE, INJECTAFER, GEMTESA, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
